Shopping Cart
Remove All
Your shopping cart is currently empty
β-Aminopropionitrile hydrochloride is a selective, orally available, irreversible inhibitor of lysyl oxidase (LOX) that reduces metastatic seeding potential in MDA-MB-231 breast cancer cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | - | In Stock | |
| 5 mg | $722 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,760 | - | In Stock |
| Description | β-Aminopropionitrile hydrochloride is a selective, orally available, irreversible inhibitor of lysyl oxidase (LOX) that reduces metastatic seeding potential in MDA-MB-231 breast cancer cells. |
| In vitro | In an in vitro model of insulin resistance, β-Aminopropionitrile hydrochloride can restore the expression of GLUT4 and adiponectin to normal levels and improve Vitis vinifera sugar uptake [1]. β-Aminopropionitrile hydrochloride (500 μM, 72 hours) can block hypoxia-induced epithelial-mesenchymal transition (EMT) morphological changes and marker protein alterations in cervical squamous cell carcinoma cells, while also inhibiting their invasion and migration capabilities (in vitro experiment) [2]. |
| In vivo | β-Aminopropionitrile hydrochloride, at a dose of 100 mg/kg/day administered orally for 6 weeks, reduced weight gain and improved metabolic profiles in diet-induced obese rats [1]. β-Aminopropionitrile hydrochloride, at a dose of 1 g/kg/day administered orally for 4 weeks, induced thoracic aortic dissection in C57BL/6 mice [3]. |
| Synonyms | BAPN hydrochloride |
| Molecular Weight | 106.55 |
| Formula | C3H7ClN2 |
| Cas No. | 646-03-7 |
| Smiles | Cl.N#CCCN |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.